Back
Avenue Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
19
ATXI
Avenue Therapeutics
Last Price:
2.21
Seasonality Move:
8.52%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.
Avenue Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.31 | Sell |
| 20-day SMA: | 2.15 | Buy |
| 50-day SMA: | 2.43 | Sell |
| 200-day SMA: | 5.79 | Sell |
| 8-day EMA: | 2.28 | Sell |
| 20-day EMA: | 2.25 | Sell |
| 50-day EMA: | 2.45 | Sell |
| 200-day EMA: | 13.9 | Sell |
Avenue Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 47.55 | Sell |
| Chaikin Money Flow: | -27866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 2.37) | Buy |
| Bollinger Bands (100): | (2.26 - 3.3) | Sell |
Avenue Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avenue Therapeutics Stock
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 2.21 while ATXI 8-day simple moving average is 2.31, which is a Sell signal.
- The stock price of ATXI is 2.21 while Avenue Therapeutics 20-day SMA is 2.15, which makes it a Buy.
- Avenue Therapeutics 50-day simple moving average is 2.43 while ATXI share price is 2.21, making it a Sell technically.
- ATXI stock price is 2.21 and Avenue Therapeutics 200-day simple moving average is 5.79, creating a Sell signal.
ATXI Technical Analysis vs Fundamental Analysis
Sell
19
Avenue Therapeutics (ATXI)
is a Sell
Is Avenue Therapeutics a Buy or a Sell?
-
Avenue Therapeutics stock is rated a Sell
The current Avenue Therapeutics [ATXI] share price is $2.21. The Score for ATXI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Avenue Therapeutics Stock Info
Market Cap:
3.17M
Price in USD:
2.21
Share Volume:
47.89K
Avenue Therapeutics 52-Week Range
52-Week High:
26.47
52-Week Low:
1.70
Sell
19
Avenue Therapeutics (ATXI)
is a Sell
Avenue Therapeutics Share Price Forecast
-
What is the Avenue Therapeutics stock price today?
The Avenue Therapeutics stock price is 2.21 USD today. -
Will ATXI stock go up or go down?
Avenue Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Avenue Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avenue Therapeutics is overvalued.
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 2.21 while ATXI 8-day exponential moving average is 2.28, which is a Sell signal.
- The stock price of ATXI is 2.21 while Avenue Therapeutics 20-day EMA is 2.25, which makes it a Sell.
- Avenue Therapeutics 50-day exponential moving average is 2.45 while ATXI share price is 2.21, making it a Sell technically.
- ATXI stock price is 2.21 and Avenue Therapeutics 200-day simple moving average is 13.90, creating a Sell signal.
Technical Analysis of Avenue Therapeutics
Should I short Avenue Therapeutics stock?
- ATXI Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Avenue Therapeutics is a Sell
- Avenue Therapeutics Relative Strength Index (RSI) is 47.55, which suggest Avenue Therapeutics is oversold
- The Bollinger Bands (25) for Avenue Therapeutics is (2.01 - 2.37), which suggest Avenue Therapeutics is a Sell
- The Bollinger Bands (100) for Avenue Therapeutics is (2.26 - 3.3), which suggest Avenue Therapeutics is a Sell
* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.